0
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Hormonal Modulation of the Responsiveness of Midbrain Central Gray Neurons to LH-RH

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The spontaneous firing rate of midbrain central gray (MCG) neurons and the effect of iontophoretically applied prolactin and luteinizing hormone releasing hormone (LH-RH) on the electrical activity of these neurons was studied in untreated and estrogen-progesterone-treated ovariectomized female rats. The spontaneous firing rate of MCG neurons as well as the neuronal membrane responsiveness to iontophoretically applied prolactin was unaffected by the presence or absence of ovarian hormones. In both treated and untreated rats, the majority of neurons were not responsive to prolactin. On the other hand, the responsiveness of MCG neurons to iontophoretically applied LH-RH was influenced by hormonal treatment. A significantly larger number of MCG neurons were inhibited by LH-RH in hormone-treated animals than in untreated rats. The present work provides evidence at the electrophysiological level that ovarian hormones do not affect the firing rate of MCG neurons but do modulate the responsiveness of MCG neurons to LH-RH.

          Related collections

          Author and article information

          Journal
          NEN
          Neuroendocrinology
          10.1159/issn.0028-3835
          Neuroendocrinology
          S. Karger AG
          0028-3835
          1423-0194
          1985
          1985
          28 March 2008
          : 41
          : 2
          : 163-168
          Affiliations
          Department of Physiology, University of Texas Health Science Center at Dallas Southwestern Medical School, Dallas, Tex., USA
          Article
          124170 Neuroendocrinology 1985;41:163–168
          10.1159/000124170
          3900788
          © 1985 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 6
          Categories
          Original Paper

          Comments

          Comment on this article